These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11227727

  • 1. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH.
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Jan; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 4. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A.
    Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
    [Abstract] [Full Text] [Related]

  • 5. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K, Remer T, Fritsche A, Häring HU, Maser-Gluth C.
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
    Ferrari P, Sansonnens A, Dick B, Frey FJ.
    Hypertension; 2001 Dec 01; 38(6):1330-6. PubMed ID: 11751713
    [Abstract] [Full Text] [Related]

  • 9. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P.
    J Clin Endocrinol Metab; 2001 Mar 01; 86(3):1247-52. PubMed ID: 11238516
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG, Dullaart RP.
    Clin Endocrinol (Oxf); 2000 Apr 01; 52(4):403-11. PubMed ID: 10762282
    [Abstract] [Full Text] [Related]

  • 12. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M, Zehnder D, Lepenies J, Petrelli MD, Moore JS, Hughes SV, Cockwell P, Hewison M, Stewart PM.
    Eur J Endocrinol; 2005 Aug 01; 153(2):291-9. PubMed ID: 16061836
    [Abstract] [Full Text] [Related]

  • 13. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K, Remer T, Haupt A, Gallwitz B, Fritsche A, Häring HU, Maser-Gluth C.
    Obesity (Silver Spring); 2008 Jun 01; 16(6):1256-60. PubMed ID: 18421276
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar 01; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

  • 16. [Effects of activity of 11β-hydroxysteroid dehydrogenase type 2 on serum potassium levels in Cushing's syndrome patients].
    Lian P, Li H, Zhang Y, Ji Z.
    Zhonghua Yi Xue Za Zhi; 2015 Mar 31; 95(12):929-32. PubMed ID: 26081057
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary cortisol to cortisone metabolites in hypertensive obese children.
    Csábi GY, Juricskay S, Molnár D.
    J Endocrinol Invest; 2000 Mar 31; 23(7):435-9. PubMed ID: 11005267
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N.
    Clin Endocrinol (Oxf); 2006 Jan 31; 64(1):37-45. PubMed ID: 16402926
    [Abstract] [Full Text] [Related]

  • 20. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK.
    Pediatr Res; 1997 Jan 31; 41(1):25-9. PubMed ID: 8979285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.